Authored and contributed to PharmaLeaders by: Gary Manning, Senior Vice President and General Manager, Healthcare, physIQ, and Mike Petrarca, Senior Vice President and General Manager, Life Sciences, physIQ For more than a few years, buzz has been steadily building around digital home hospital care models. However, the pandemic has accelerated enthusiasm for taking the … [Read more...]
Pharma Leadership: Cultivating Talent in Uncertain Times
Article contributed to PharmaLeaders and authored by: Beth Doladee, M.A., M.B.A., Managing Consultant and Neelima Paranjpey, Ph.D., Managing Consultant, The Vaya Group Executive Summary Today’s highly dynamic, fast-paced pharmaceutical industry requires knowledge preservation and leaders who understand these unique challenges. This means developing leadership from within, … [Read more...]
How Training Simulations Will Help Pharma Sales Teams in the Post-Pandemic Market
Article contributed to PharmaLeaders and authored by: Jeremy Lovelace, founder and director of HFX Training. Across all industries, sales teams face an uncertain future, and pharma is no different. Many key sales practices, such as healthcare provider meetings and terrority-focused engagement have been replaced by the unfamiliar environment of zoom calls, … [Read more...]
Healthcare M&A on the Rise: 5 Principles for Creating a New Brand that Resonates
Article contributed to PharmaLeaders by Matt Egan, Executive Director, Strategy at Siegel+Gale A wave of M&A deals is coming to the healthcare industry. According to consulting firm BDO, 44% of healthcare CFOs are expecting to drive an increase in partnerships across the healthcare ecosystem and 42% are predicting further consolidation. The pandemic accelerated digital … [Read more...]
Patient-Centered Approaches to Clinical Research in Oncology
Article contributed to PharmaLeaders by Edward F. Ikeguchi, M.D., the Chief Executive Officer at AiCure Most of us have personal experiences with cancer, whether ourselves or with loved ones. We know that cancer is frightening and that treatment regimens can be stressful, exhausting and overwhelming. Patients participating in drug trials for oncology are subject to a list of … [Read more...]